πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8303984

Skin treatment compositions containing copper-pigment complexes

Discovery Limited Β· Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8298555

Color cosmetic compositions for topical anti-aging skin treatment

Discovery Limited Β· Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8298521

Treatment for eye disorder

The Regents of the University of California Β· Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8293800

Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the tre

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8273729

Treatment of irritable bowel syndrome and related bowel disease

The Board of Regents of the University of Texas System Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8268336

Compositions containing aromatic aldehydes and their use in treatments

SkinMedica, Inc. Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8269014

Thiophene analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals (Canada) Incorporated Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8268894

Compositions and methods for the treatment of infectious diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8268825

Method for the treatment of anthrax infections

The Board of Regents for Oklahoma State University Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8263650

Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatme

Jazz Pharmaceuticals, Inc. Β· Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8258116

Combination therapy for the treatment of HCV infection

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8258278

Methods and compositions for the treatment and prevention of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8257915

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosc

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8252836

Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for th

The Board of Regents of the University of Texas System Β· Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8247183

Compositions and methods for diagnosis and treatment of tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8246971

Compositions containing aromatic aldehydes and their use in treatment

SkinMedica, Inc. Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8246969

Compositions containing aromatic aldehydes and their use in treatments

SkinMedica, Inc. Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8242085

Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections an

BioCryst Pharmaceuticals, Inc. Β· Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8236983

Composition and method for the treatment of diseases affected by apoptosis

The Board of Regents of the University of Texas System Β· Granted Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8236987

Selective estrogen receptor modulator compositions and methods for treatment of disease

The Regents of the University of California Β· Granted Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8232373

Immunogenic peptide composition for the prevention and treatment of alzheimer's disease

United Biomedical, Inc. Β· Granted Tue Jul 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8227246

Compositions of adult disc stem cells for the treatment of degenerative disc disease

DiscGenics, Inc. Β· Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8227494

Pharmaceutical compositions of 1,2,4-oxadiazole benzoic acid and their use for the treatme

PTC THERAPEUTICS, INC. Β· Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8216614

Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosi

The Board of Regents of the University of Texas System Β· Granted Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted